AI assistant
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2015
May 23, 2015
10216_dirs_2015-05-22_e0f3a40d-8c76-426d-9bd0-706dfe429295.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-05-20
Reporting Person: PRINS RICHARD K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-20 | Common Stock | M | 13945 | $11.68 | Acquired | 49996 | Direct |
| 2015-05-20 | Common Stock | S | 13945 | $14.7904 | Disposed | 36051 | Direct |
| 2015-05-21 | Common Stock | M | 11901 | $11.68 | Acquired | 47952 | Direct |
| 2015-05-21 | Common Stock | M | 1664 | $10.77 | Disposed | 49616 | Direct |
| 2015-05-21 | Common Stock | S | 13565 | $14.757 | Disposed | 36051 | Direct |
| 2015-05-22 | Common Stock | M | 1942 | $10.77 | Acquired | 37993 | Direct |
| 2015-05-22 | Common Stock | S | 1942 | $14.755 | Disposed | 36051 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-20 | Stock Option (right to buy) | $11.68 | M | 13945 | Disposed | 2015-12-18 | Common Stock (13945) | Direct |
| 2015-05-21 | Stock Option (right to buy) | $11.68 | M | 11901 | Disposed | 2015-12-18 | Common Stock (11901) | Direct |
| 2015-05-21 | Stock Option (right to buy) | $10.77 | M | 1664 | Disposed | 2017-12-15 | Common Stock (1664) | Direct |
| 2015-05-22 | Stock Option (right to buy) | $10.77 | M | 1942 | Disposed | 2017-12-15 | Common Stock (1942) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $14.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $15.00, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $14.80, inclusive.
F4: Shares subject to the option are fully vested and immediately exercisable.